Follow us on

They intend to extend the legal limit for research on human embryos

Science seeks to extend the legal deadline for experimenting with human embryos, but ethical doubts are growing about respecting life from the beginning

They intend to extend the legal limit for research on human embryos

In December 2024, the UK’s Human Fertilization and Embryology Authority (HFEA) proposed to the government that the legal limit for human embryo culture be extended from 14 to 28 days. Although this proposal has not yet been officially implemented, it could have global repercussions, given the UK’s pioneering role in regulating embryo research. This was recently reported in the journal  Nature .

Since 1990, the “14-day rule” has been an international consensus, serving as the ethical and scientific limit for embryonic research. This timeframe is based on the appearance of the primitive streak, a key marker of embryonic development that precedes embryonic individuality. However, technological advances now allow cultivation beyond this limit, opening the door to investigating crucial developmental stages that occur between days 14 and 28, such as neural tube closure, early organ formation, and gamete precursors.

Extending this timeframe would allow for a better understanding of the origin of congenital anomalies, placental development, and the causes of infertility, as well as promote the use of stem cell-derived embryonic models. These models, which mimic developmental stages, are also subject to the 14-day rule in several countries, limiting their usefulness.

Despite the scientific benefits, the proposed change raises ethical concerns. Some fear a “slippery slope” toward unethically acceptable practices, such as the creation of embryos for eugenic purposes. While milestones such as a heartbeat or the formation of limbs may generate public concern, the neurons and circuits necessary for sensory perception do not develop until many weeks later, which would seemingly support the proposed new threshold from an ethical standpoint.

The article suggests that any changes to the legal framework should be transparent, based on scientific evidence, and accompanied by broad public participation. Citizen consultations, panels, and forums are recommended to inform and receive feedback. The UK’s experience in other areas of bioethics demonstrates that these processes can foster public trust and avoid unjustified alarmism.

It is also proposed to implement pilot projects in accredited centers before adopting the new limit generally. These experiments must be supervised by ethics and regulatory committees, with periodic scientific reviews. Furthermore, it is essential to establish real-time monitoring systems, publish anonymized data, and encourage information sharing between institutions.

At the international level, harmonizing criteria would allow progress to be made without generating legal or ethical conflicts between countries. While each nation has its own approach, organizations such as the WHO or international scientific societies could guide the development of shared principles. It is suggested that an annual conference be created to bring together experts to review progress and adjust regulations in accordance with scientific developments and social values.

In conclusion, extending the embryo culture limit to 28 days—or until the closure of the neural tube—could open new frontiers in reproductive medicine and genetics. However, this step must be taken with caution, rigorous oversight, and ongoing social dialogue to maintain ethical integrity and public trust.

This is the argument presented to us for delaying experimentation on human embryos to 28 days. As can be seen, these are utilitarian reasons. No one can dispute that, if we allow the human embryo to grow for observation, we can gain greater knowledge. However, this is no justification for threatening its life—the life of a living human organism, a human being, a person.

The International Society for Stem Cell Research  (ISSCR) had already proposed in 2021 to lift the ban on further research involving human embryos  beyond 14 days. In reality, considering 14 or 28 days as decisive for marking the beginning of human life seems arbitrary. In 1979, the United States Ethics Advisory Board (EAB) published a report on May 4 arguing that the human embryo, during its first 14 days of development—the stage in which the primitive trophoblast line, the precursor structure of the spinal cord, is formed and which coincides with the implantation and consolidation of the blastocyst in the maternal endometrium—could not be considered a fully formed individual. According to the committee, during this initial period, the embryo represented only a form of human life in progress, with a high mortality rate and no defined individuality.

Based on this premise, the report concluded that, at this stage, the embryo should not be given a specific moral status, which opened up the possibility of authorizing scientific research using embryonic material, without its destruction posing a significant ethical dilemma.

Five years later, in 1984, the Warnock Commission of the United Kingdom took up and reinforced this approach in a new report that legitimized research on human embryos up to 14 days after conception. This commission adopted the same time limit proposed by the American EAB, thus reaffirming the conventional and arbitrary nature of this threshold. Along the same lines, one of its members, embryologist Dr. Anne McLaren, went so far as to declare that one cannot speak of human life properly speaking before the formation of the primitive streak in the trophoblast, approximately on day 14 after fertilization.

Today, biology clearly demonstrates that the life of a new human being begins at the moment of fertilization, when the oocyte and sperm fuse and the zygote is formed, with its own phenotype and the axes that will guide its development. The genetic identity of the embryo, together with the epigenetic processes that activate a continuous and increasingly complex development program, as well as the data provided by embryonic proteomics and the positional information of cells in the process of differentiation and organization from the earliest stages, contradict the idea that the initial embryo lacks its own individuality, as some have argued.

From the first cell division, the two resulting cells assume distinct functions: one will give rise to the inner cell mass and the other to the extraembryonic tissues. Ignoring this scientific evidence opens the door to serious ethical consequences, as respect for human life in its initial stages is lost. In this vacuum, utilitarian metabioethics gains strength and comes to justify what is, in reality, unjustifiable. If the objective is to develop new therapies or obtain organs for transplants, then the use of human embryos—which will die when their inner cell mass is removed or when their stem cells are used to form chimeras—is presented as valid within this logic, where the end ultimately justifies the means.

Jaime Millás

Licenciado en Ciencias Biológicas, por la Universidad de Valencia (España), ciudad donde nació en 1953, es licenciado en Ciencias de la Educación por la Universidad de Piura (Perú) y Máster en Dirección de Instituciones Educativas por el Centro Universitario Villanueva, adscrito a la Universidad Complutense de Madrid. También es Máster en Bioética por la Universidad de Murcia (España) y Doctor en Bioética por la Universidad Católica de Valencia (España) con una tesis sobre “Reflexión bioética sobre la opinión de los médicos peruanos acerca de la aplicación de la terapia con células madre en clínicas de Latinoamérica” (Sobresaliente Cum Laude). En Valencia fue subdirector del Colegio Mayor “Albalat” y, tras fijar su residencia en el Perú, en 1977, director de varios Centros Culturales de Lima y del Colegio Alpamayo desde 1988 hasta 2004. Ha sido vicepresidente del Centro de Orientación Familiar (COFAM) y trabajó en la oficina de proyectos de la Asociación para el Desarrollo de la Enseñanza Universitaria (ADEU), entidad promotora de la Universidad de Piura. Asimismo ha sido secretario de la Asociación Civil “Piura 450”, promotora de colegios en Chiclayo y Piura. También ha sido director del Colegio “Turicará” de Piura entre los años 2005 y 2012. Actualmente se desempeña como presidente del Comité Institucional de Ética en Investigación de la Universidad de Piura. Director del Departamento de Ciencias Básicas y Bioética, y director de Estudios de la Facultad de Medicina de la Universidad de Piura. Coautor del libro “Bioética en Investigación. Fundamentos, principios, aplicaciones”. Y autor de otros libros de Bioética y educación, así como artículos de Bioética en revistas indexadas.